NASDAQ: DMII
Drugs Made In America Acquisition II Corp Stock Ownership - Who owns Drugs Made In America Acquisition II?

Insider buying vs selling

Have Drugs Made In America Acquisition II Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when DMII insiders and whales buy or sell their stock.

DMII Shareholders

What type of owners hold Drugs Made In America Acquisition II Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Drugs Made In America Acquisition II LLC10.53%6,708,333$67.62MInsider
Lynn Stockwell10.53%6,708,333$67.62MInsider
Mmcap International Inc Spc4.24%2,700,000$27.22MInstitution
Magnetar Financial LLC4.24%2,700,000$27.22MInstitution
Karpus Management Inc4.08%2,597,923$26.19MInstitution
Glazer Capital LLC3.69%2,349,761$23.69MInstitution
Lmr Partners LLP3.14%2,000,000$20.16MInstitution
Healthcare Of Ontario Pension Plan Trust Fund3.14%2,000,000$20.16MInstitution
Millennium Management LLC3.10%1,976,425$19.92MInstitution
Hudson Bay Capital Management LP3.09%1,969,030$19.85MInstitution

1 of 3

DMII vs Shell Company Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DMII75.79%21.69%
BCSS75.63%0.00%
EVAC75.53%3.01%
CEPF72.60%4.72%Net Buying
GPAT49.51%0.00%

Drugs Made In America Acquisition II Stock Ownership FAQ

Who owns Drugs Made In America Acquisition II?

Drugs Made In America Acquisition II (NASDAQ: DMII) is owned by 75.79% institutional shareholders, 21.69% Drugs Made In America Acquisition II insiders, and 2.52% retail investors. Drugs Made In America Acquisition II LLC is the largest individual Drugs Made In America Acquisition II shareholder, owning 6.71M shares representing 10.53% of the company. Drugs Made In America Acquisition II LLC's Drugs Made In America Acquisition II shares are currently valued at $67.62M.

If you're new to stock investing, here's how to buy Drugs Made In America Acquisition II stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.